Skip to main content

Table 1 Clinical–epidemiological characteristics of the population with CKD according to the NLR level

From: Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as risk factors for mortality in Peruvian adults with chronic kidney disease

Characteristics All (n = 343) NLR p value
High (n = 50) Normal (n = 293)
Age (years)* 78.3 (11.9) 76.8 (10.8) 78.5 (12.1) 0.33
Sex** 0.27
Female 127 (37.1) 15 (30.0) 112 (38.2)  
Male 216 (62.9) 35 (70.0) 181(61.8)  
Hypertension** 0.60
Yes 222 (64.7) 34 (68.0) 188 (64.2)  
No 121 (35.3) 16 (32.0) 105 (35.8)  
Diabetes** 0.50
Yes 103 (30.0) 13 (26.0) 90 (30.7)  
No 240 (70.0) 37 (74.0) 203 (69.3)  
CKD stage** 0.82
1–2 22 (6.4) 4 (8.0) 18 (6.1)  
3a–3b 311 (90.7) 45 (90.0) 266 (90.8)  
4–5 10 (2.9) 1 (2.0) 9 (3.1)  
Laboratory profile  
Serum creatinine (mg/dL)* 1.4 (0.5) 1.4 (0.3) 1.4 (0.5) 0.92
eGFR (ml/min/1.73 m2)* 47.4 (10.5) 47.6 (10.3) 47.4 (10.6) 0.88
Glucose (mg/dL)*** 90 (83–104) 88.5 (82–109) 90 (83–103) 0.98
Total protein (g/dL)* 7.2 (0.6) 7.1 (0.6) 7.3 (0.6) 0.08
Albumin (g/dL)* 4.1 (0.4) 4.1 (0.4) 4.2 (0.4) 0.12
AST (U/L)*** 23 (19–28) 23 (16–27) 23(19–28) 0.12
ALT (U/L)*** 18(13–24) 19 (14–24) 18(13–24) 0.56
Total bilirubin (mg/dL)*** 0.6 (0.4–0.8) 0.6 (0.5–0.8) 0.6 (0.4–0.8) 0.29
Alkaline phosphatase (U/L)*** 101 (82–128) 114 (85–148) 100 (82–124) 0.03
Globulin (g/dL)* 3.1 (0.7) 3.1 (0.6) 3.1 (0.8) 0.57
Hemoglobin (g/dL)* 12.2 (1.7) 12.1 (1.7) 12.2 (1.7) 0.70
Platelets (K/uL)* 237.9 (82.4) 260.7 (10.6) 234.1 (78.1)  < 0.01
  1. eGFR estimated glomerular filtration rate, CKD chronic kidney disease, AST aspartate aminotransferase, ALT alanine aminotransferase, NLR neutrophil–lymphocyte ratio
  2. *Mean (standard deviation)
  3. **Frequency (percent)
  4. ***Median (p25–p75)